A Global Icon Reimagined Through Health, Innovation & Strategic Growth
Rooted in nearly a century of food science expertise, Danone has evolved into a trusted name in global nutrition. With headquarters in Paris and a universe of brands—think Sensodyne-level clarity, but in dairy and health—Danone spans categories from Activia yogurt and Evian water to specialized infant formulas and medical nutrition.
In the first quarter of 2025, Danone surpassed analysts’ expectations with a 4.3% like-for-like sales increase (€6.844 billion), showcasing resilience through premium products like Essensis infant formula in China, strong dairy protein offerings in North America, and sustained water and coffee creamer demand despite elevated dairy costs.
Resilience through Renewal
Danone’s “Renew” strategy began in 2022 and has since reshaped the company—prioritizing culture, execution, and financial discipline. CEO Antoine de Saint‑Affrique describes this renewed era as fundamentally about focusing on science-led products, operational rigor, and proactive portfolio alignment. That approach delivered €27.4 billion in sales (+4.3% LFL) and record €3 billion free cash flow in 2024—enabling a subsequent 2.4% dividend increase to €2.15 and support for growth through value-based investments.
Powering Innovation: Science Meets Nutrition
Danone’s commitment to health and science is elevating its competitive edge. The company is leaning into high-growth arenas—including protein-rich foods, coffee-enhanced dairy, and medical nutrition. In China, Essensis continues to fuel market share gains, while Mizone fortified water has soared 12% in APAC. The Renew strategy’s upcoming phase also includes targeted expansion into India and Southeast Asia, through both organic development and selective acquisitions.
Strategic Growth and Portfolio Management
With its robust cash position and strong operating margins (13% in 2024), Danone is positioned to invest wisely. The company plans to deploy capital into science-driven acquisitions within medical nutrition and health-forward food brands, creating a more balanced and resilient portfolio. As de Saint‑Affrique affirms: “We want to move to the front foot on acquisitions.”
